Therapeutic angiogenesis in a murine model of limb ischemia by recombinant periostin and its fasciclin I domain

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 9, 2014, Pages 1324-1332

  Kim, Ba Reun ^a   Jang, Il Ho ^a   Shin, Sang Hun ^a   Kwon, Yang Woo ^a   Heo, Soon Chul ^a   Choi, Eun Jung ^a   Lee, Jung Sub ^a   Kim, Jae Ho ^a,b  

^a Pusan National University School of Medicine   (South Korea)

^b Pusan National University Yangsan Hospital   (South Korea)

Author keywords

Endothelial colony forming cell; Homing; Ischemia; Neovascularization; Periostin

Indexed keywords

FASCICLIN I; TRANSCRIPTION FACTOR RUNX2; BETA3 INTEGRIN; BETA5 INTEGRIN; BLOCKING ANTIBODY; RECOMBINANT PERIOSTIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL HOMING; CELL MIGRATION; COLONY FORMING CELL; CONTROLLED STUDY; ENDOTHELIAL COLONY FORMING CELL; ESCHERICHIA COLI; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIMB ISCHEMIA; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; CHEMOTAXIS; ENDOTHELIUM CELL; HINDLIMB; HUMAN TISSUE; LIMB REGENERATION; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROTEIN DOMAIN;

ENDOTHELIAL COLONY FORMING CELL; HOMING; ISCHEMIA; NEOVASCULARIZATION; PERIOSTIN;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; BLOTTING, WESTERN; CELL ADHESION; CELL ADHESION MOLECULES; CELL ADHESION MOLECULES, NEURONAL; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; FLUORESCENT ANTIBODY TECHNIQUE; HINDLIMB; HUMANS; INJECTIONS, INTRAMUSCULAR; ISCHEMIA; MALE; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; RECOMBINANT PROTEINS;

EID: 84903454064     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2014.05.004     Document Type: Article

References (48)

1. Erdmann E., Dormandy J.A., Charbonnel B., Massi-Benedetti M., Moules I.K., Skene A.M., Investigators P. The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) study. J. Am. Coll. Cardiol. 2007, 49:1772-1780.
2. Carmeliet P. Angiogenesis in health and disease. Nat. Med. 2003, 9:653-660.
3. Tongers J., Losordo D.W., Landmesser U. Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges. Eur. Heart J. 2011, 32:1197-1206.
4. Tongers J., Roncalli J.G., Losordo D.W. Therapeutic angiogenesis for critical limb ischemia: microvascular therapies coming of age. Circulation 2008, 118:9-16.
5. Yoo S.Y., Kwon S.M. Angiogenesis and its therapeutic opportunities. Mediators Inflamm. 2013, 2013:127170.
6. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., Witzenbichler B., Schatteman G., Isner J.M. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
7. Asahara T., Masuda H., Takahashi T., Kalka C., Pastore C., Silver M., Kearne M., Magner M., Isner J.M. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 1999, 85:221-228.
8. Asahara T., Takahashi T., Masuda H., Kalka C., Chen D., Iwaguro H., Inai Y., Silver M., Isner J.M. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J. 1999, 18:3964-3972.
9. Kong D., Melo L.G., Gnecchi M., Zhang L., Mostoslavsky G., Liew C.C., Pratt R.E., Dzau V.J. Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation 2004, 110:2039-2046.
10. Wang C.H., Ting M.K., Verma S., Kuo L.T., Yang N.I., Hsieh I.C., Wang S.Y., Hung A., Cherng W.J. Pioglitazone increases the numbers and improves the functional capacity of endothelial progenitor cells in patients with diabetes mellitus. Am. Heart J. 2006, 152:1051.e1051-1051.e1058.
11. Raval Z., Losordo D.W. Cell therapy of peripheral arterial disease: from experimental findings to clinical trials. Circ. Res. 2013, 112:1288-1302.
12. Hung H.S., Shyu W.C., Tsai C.H., Hsu S.H., Lin S.Z. Transplantation of endothelial progenitor cells as therapeutics for cardiovascular diseases. Cell Transplant. 2009, 18:1003-1012.
13. Horiuchi K., Amizuka N., Takeshita S., Takamatsu H., Katsuura M., Ozawa H., Toyama Y., Bonewald L.F., Kudo A. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J. Bone Miner. Res. 1999, 14:1239-1249.
14. Gillan L., Matei D., Fishman D.A., Gerbin C.S., Karlan B.Y., Chang D.D. Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility. Cancer Res. 2002, 62:5358-5364.
15. Morra L., Moch H. Periostin expression and epithelial-mesenchymal transition in cancer: a review and an update. Virchows Arch. 2011, 459:465-475.
16. Kudo Y., Siriwardena B.S., Hatano H., Ogawa I., Takata T. Periostin: novel diagnostic and therapeutic target for cancer. Histol. Histopathol. 2007, 22:1167-1174.
17. Kudo A. Periostin in fibrillogenesis for tissue regeneration: periostin actions inside and outside the cell. Cell. Mol. Life Sci. 2011, 68:3201-3207.
18. Ruan K., Bao S., Ouyang G. The multifaceted role of periostin in tumorigenesis. Cell. Mol. Life Sci. 2009, 66:2219-2230.
19. Zhu M., Fejzo M.S., Anderson L., Dering J., Ginther C., Ramos L., Gasson J.C., Karlan B.Y., Slamon D.J. Periostin promotes ovarian cancer angiogenesis and metastasis. Gynecol. Oncol. 2010, 119:337-344.
20. Shao R., Bao S., Bai X., Blanchette C., Anderson R.M., Dang T., Gishizky M.L., Marks J.R., Wang X.F. Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression. Mol. Cell. Biol. 2004, 24:3992-4003.
21. Kalka C., Masuda H., Takahashi T., Gordon R., Tepper O., Gravereaux E., Pieczek A., Iwaguro H., Hayashi S.I., Isner J.M., Asahara T. Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects. Circ. Res. 2000, 86:1198-1202.
22. Kalka C., Masuda H., Takahashi T., Kalka-Moll W.M., Silver M., Kearney M., Li T., Isner J.M., Asahara T. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:3422-3427.
23. Hakuno D., Kimura N., Yoshioka M., Mukai M., Kimura T., Okada Y., Yozu R., Shukunami C., Hiraki Y., Kudo A., Ogawa S., Fukuda K. Periostin advances atherosclerotic and rheumatic cardiac valve degeneration by inducing angiogenesis and MMP production in humans and rodents. J. Clin. Invest. 2010, 120:2292-2306.
24. Hakuno D., Kimura N., Yoshioka M., Fukuda K. Role of angiogenetic factors in cardiac valve homeostasis and disease. J. Cardiovasc. Transl. Res. 2011, 4:727-740.
25. Kudo Y., Iizuka S., Yoshida M., Nguyen P.T., Siriwardena S.B., Tsunematsu T., Ohbayashi M., Ando T., Hatakeyama D., Shibata T., Koizumi K., Maeda M., Ishimaru N., Ogawa I., Takata T. Periostin directly and indirectly promotes tumor lymphangiogenesis of head and neck cancer. PLoS ONE 2012, 7:e44488.
26. Losordo D.W., Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies. Circulation 2004, 109:2692-2697.
27. Nam J.O., Son H.N., Jun E., Cha K., Lee B.H., Park R.W., Kim I.S. FAS1 domain protein inhibits VEGF165-induced angiogenesis by targeting the interaction between VEGFR-2 and αvβ3 integrin. Mol. Cancer Res. 2012, 10:1010-1020.
28. Li G., Jin R., Norris R.A., Zhang L., Yu S., Wu F., Markwald R.R., Nanda A., Conway S.J., Smyth S.S., Granger D.N. Periostin mediates vascular smooth muscle cell migration through the integrins alphavbeta3 and alphavbeta5 and focal adhesion kinase (FAK) pathway. Atherosclerosis 2010, 208:358-365.
29. Watanabe T., Yasue A., Fujihara S., Tanaka E. PERIOSTIN regulates MMP-2 expression via the αvβ3 integrin/ERK pathway in human periodontal ligament cells. Arch. Oral Biol. 2012, 57:52-59.
30. Lee Y.J., Kim I.S., Park S.A., Kim Y., Lee J.E., Noh D.Y., Kim K.T., Ryu S.H., Suh P.G. Periostin-binding DNA aptamer inhibits breast cancer growth and metastasis. Mol. Ther. 2013, 21:1004-1013.
31. Kühn B., del Monte F., Hajjar R.J., Chang Y.S., Lebeche D., Arab S., Keating M.T. Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat. Med. 2007, 13:962-969.
32. Shimazaki M., Nakamura K., Kii I., Kashima T., Amizuka N., Li M., Saito M., Fukuda K., Nishiyama T., Kitajima S., Saga Y., Fukayama M., Sata M., Kudo A. Periostin is essential for cardiac healing after acute myocardial infarction. J. Exp. Med. 2008, 205:295-303.
33. Ontsuka K., Kotobuki Y., Shiraishi H., Serada S., Ohta S., Tanemura A., Yang L., Fujimoto M., Arima K., Suzuki S., Murota H., Toda S., Kudo A., Conway S.J., Narisawa Y., Katayama I., Izuhara K., Naka T. Periostin, a matricellular protein, accelerates cutaneous wound repair by activating dermal fibroblasts. Exp. Dermatol. 2012, 21:331-336.
34. Cho Y.H., Cha M.J., Song B.W., Kim I.K., Song H., Chang W., Lim S., Ham O., Lee S.Y., Choi E., Kwon H.M., Hwang K.C. Enhancement of MSC adhesion and therapeutic efficiency in ischemic heart using lentivirus delivery with periostin. Biomaterials 2012, 33:1376-1385.
35. Ladage D., Yaniz-Galende E., Rapti K., Ishikawa K., Tilemann L., Shapiro S., Takewa Y., Muller-Ehmsen J., Schwarz M., Garcia M.J., Sanz J., Hajjar R.J., Kawase Y. Stimulating myocardial regeneration with periostin peptide in large mammals improves function post-myocardial infarction but increases myocardial fibrosis. PLoS ONE 2013, 8:e59656.
36. Wallace D.P., White C., Savinkova L., Nivens E., Reif G.A., Pinto C.S., Raman A., Parnell S.C., Conway S.J., Fields T.A. Periostin promotes renal cyst growth and interstitial fibrosis in polycystic kidney disease. Kidney Int. 2014, 85:845-854.
37. Naik P.K., Bozyk P.D., Bentley J.K., Popova A.P., Birch C.M., Wilke C.A., Fry C.D., White E.S., Sisson T.H., Tayob N., Carnemolla B., Orecchia P., Flaherty K.R., Hershenson M.B., Murray S., Martinez F.J., Moore B.B., Investigators C. Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 2012, 303:L1046-L1056.
38. Koh T.J., DiPietro L.A. Inflammation and wound healing: the role of the macrophage. Expert Rev. Mol. Med. 2011, 13:e23.
39. Conway S.J., Izuhara K., Kudo Y., Litvin J., Markwald R., Ouyang G., Arron J.R., Holweg C.T., Kudo A. The role of periostin in tissue remodeling across health and disease. Cell. Mol. Life Sci. 2014, 71:1279-1288.
40. Maeng Y.S., Choi H.J., Kwon J.Y., Park Y.W., Choi K.S., Min J.K., Kim Y.H., Suh P.G., Kang K.S., Won M.H., Kim Y.M., Kwon Y.G. Endothelial progenitor cell homing: prominent role of the IGF2-IGF2R-PLCbeta2 axis. Blood 2009, 113:233-243.
41. Takeshita S., Zheng L.P., Brogi E., Kearney M., Pu L.Q., Bunting S., Ferrara N., Symes J.F., Isner J.M. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J. Clin. Invest. 1994, 93:662-670.
42. Lucerna M., Zernecke A., de Nooijer R., de Jager S.C., Bot I., van der Lans C., Kholova I., Liehn E.A., van Berkel T.J., Yla-Herttuala S., Weber C., Biessen E.A. Vascular endothelial growth factor-A induces plaque expansion in ApoE knock-out mice by promoting de novo leukocyte recruitment. Blood 2007, 109:122-129.
43. Askari A.T., Unzek S., Popovic Z.B., Goldman C.K., Forudi F., Kiedrowski M., Rovner A., Ellis S.G., Thomas J.D., DiCorleto P.E., Topol E.J., Penn M.S. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003, 362:697-703.
44. Caiado F., Dias S. Endothelial progenitor cells and integrins: adhesive needs. Fibrogenesis Tissue Repair 2012, 5:4.
45. Fu S.S., Li F.J., Wang Y.Y., You A.B., Qie Y.L., Meng X., Li J.R., Li B.C., Zhang Y., Da Li Q. Kallikrein gene-modified EPCs induce angiogenesis in rats with ischemic hindlimb and correlate with integrin αvβ3 expression. PLoS ONE 2013, 8:e73035.
46. Wijelath E.S., Rahman S., Murray J., Patel Y., Savidge G., Sobel M. Fibronectin promotes VEGF-induced CD34 cell differentiation into endothelial cells. J. Vasc. Surg. 2004, 39:655-660.
47. Kokubo T., Uchida H., Choi E.T. Integrin alpha(v)beta(3) as a target in the prevention of neointimal hyperplasia. J. Vasc. Surg. 2007, 45(Suppl. A):A33-A38.
48. Napoli C., Hayashi T., Cacciatore F., Casamassimi A., Casini C., Al-Omran M., Ignarro L.J. Endothelial progenitor cells as therapeutic agents in the microcirculation: an update. Atherosclerosis 2011, 215:9-22.